Logo image of SRTS

SENSUS HEALTHCARE INC (SRTS) Stock Analyst Earnings Estimates

NASDAQ:SRTS - Nasdaq - US81728J1097 - Common Stock - Currency: USD

5.5  -0.08 (-1.43%)

After market: 5.3037 -0.2 (-3.57%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
SRTS revenue by date.SRTS revenue by date.
44.53M
64.68%
24.405M
-45.19%
41.807M
71.31%
43.617M
4.33%
55.281M
26.74%
65.095M
17.75%
65.965M
1.34%
75.86M
15.00%
87.24M
15.00%
EBITDA
YoY % growth
SRTS ebitda by date.SRTS ebitda by date.
15.15M
220.30%
79K
-99.48%
8.522M
10,687.34%
3.254M
-61.82%
9.418M
189.43%
18.496M
96.39%
34.478M
86.41%
65.835M
90.95%
128.23M
94.77%
EBIT
YoY % growth
SRTS ebit by date.SRTS ebit by date.
14.83M
259.95%
-382K
-102.58%
8.09M
2,217.80%
5.16M
-36.22%
12.057M
133.66%
12.227M
1.41%
4.663M
-61.86%
5.362M
14.99%
6.167M
15.01%
Operating Margin
SRTS operating margin by date.SRTS operating margin by date.
33.30%-1.57%19.35%11.83%21.81%18.78%7.07%7.07%7.07%
EPS
YoY % growth
SRTS eps by date.SRTS eps by date.
0.68
183.33%
0.03
-95.59%
0.40
1,233.33%
0.11
-71.95%
0.49
332.73%
0.59
20.80%
0.27
-54.78%
0.31
15.38%
0.35
13.33%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
0.03
-73.48%
0.07
4.91%
0.17
90.40%
0.15
195.63%
0.10
284.62%
0.06
-16.67%
0.14
-16.67%
Revenue
Q2Q % growth
9.487M
2.68%
10.881M
23.10%
14.797M
13.24%
12.886M
54.43%
9.894M
4.29%
8.976M
-17.51%
11.628M
-21.42%
EBITDA
Q2Q % growth
1.139M
-47.70%
2.685M
49.75%
3.958M
83.41%
3.468M
238.66%
2.142M
88.06%
1.428M
-46.82%
3.06M
-22.69%
EBIT
Q2Q % growth
287.028K
-85.52%
1.176M
-21.34%
3.316M
92.12%
3.213M
221.43%
1.938M
575.20%
1.326M
12.76%
2.958M
-10.80%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
-0.16
-214.29%
0.03-0.19-561.36%
Q4 2024
Q2Q % growth
0.09
-65.38%
0.13-0.04-28.84%
Q3 2024
Q2Q % growth
0.07
177.78%
-0.010.08786.27%
Q2 2024
Q2Q % growth
0.10
600.00%
0.020.08320.23%
Q1 2024
Q2Q % growth
0.14
216.67%
-0.060.20349.55%
Q4 2023
Q2Q % growth
0.26
52.94%
0.120.14108.94%
Q3 2023
Q2Q % growth
-0.09
-181.82%
-0.02-0.07-390.20%
Q2 2023
Q2Q % growth
-0.02
-109.52%
-0.080.0674.20%
Q1 2023
Q2Q % growth
-0.12
-163.16%
0.13-0.25-191.91%
Q4 2022
Q2Q % growth
0.17
-46.88%
0.23-0.06-27.54%
Q3 2022
Q2Q % growth
0.11
1,000.00%
0.13-0.02-14.41%
Q2 2022
Q2Q % growth
0.21
1,150.00%
0.130.0855.97%
Q1 2022
Q2Q % growth
0.19
371.43%
0.34-0.15-43.55%
Q4 2021
Q2Q % growth
0.32
1,500.00%
0.170.1591.30%
Q3 2021
Q2Q % growth
0.01
107.14%
-0.020.03158.81%
Q2 2021
Q2Q % growth
-0.02
87.50%
-0.060.0464.35%
Q1 2021
Q2Q % growth
-0.07
68.18%
-0.100.0330.21%
Q4 2020
Q2Q % growth
0.02
-66.67%
-0.110.13117.56%
Q3 2020
Q2Q % growth
-0.14
-250.00%
-0.140.00-1.67%
Q2 2020
Q2Q % growth
-0.16
-1,700.00%
-0.180.0212.85%
Q1 2020
Q2Q % growth
-0.22
-69.23%
-0.07-0.15-215.65%
Q4 2019
Q2Q % growth
0.06 0.030.03107.64%
Q3 2019
Q2Q % growth
-0.04 -0.03-0.01-17.66%
Q2 2019
Q2Q % growth
0.01 -0.050.06119.06%
Q1 2019
Q2Q % growth
-0.13 -0.03-0.10-271.69%
SRTS Yearly EPS VS EstimatesSRTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 1.5
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
8.344M
-21.75%
7.379M965K13.08%
Q4 2024
Q2Q % growth
13.067M
3.99%
11.062M2.005M18.13%
Q3 2024
Q2Q % growth
8.839M
126.76%
6.013M2.826M47.00%
Q2 2024
Q2Q % growth
9.239M
104.09%
7.142M2.097M29.36%
Q1 2024
Q2Q % growth
10.663M
212.33%
4.202M6.461M153.76%
Q4 2023
Q2Q % growth
12.566M
-4.08%
11.281M1.285M11.39%
Q3 2023
Q2Q % growth
3.898M
-56.74%
6.002M-2.104M-35.05%
Q2 2023
Q2Q % growth
4.527M
-62.52%
4.641M-114K-2.46%
Q1 2023
Q2Q % growth
3.414M
-66.98%
10.336M-6.922M-66.97%
Q4 2022
Q2Q % growth
13.1M
0.54%
13.241M-141K-1.06%
Q3 2022
Q2Q % growth
9.01M
62.93%
9.729M-719K-7.39%
Q2 2022
Q2Q % growth
12.08M
122.88%
9.747M2.333M23.94%
Q1 2022
Q2Q % growth
10.34M
236.81%
6.867M3.473M50.58%
Q4 2021
Q2Q % growth
13.03M
155.99%
11.308M1.722M15.23%
Q3 2021
Q2Q % growth
5.53M
241.36%
5.681M-151K-2.66%
Q2 2021
Q2Q % growth
5.42M
359.32%
4.366M1.054M24.14%
Q1 2021
Q2Q % growth
3.07M
82.74%
3.767M-697K-18.50%
Q4 2020
Q2Q % growth
5.09M
-40.19%
2.578M2.512M97.44%
Q3 2020
Q2Q % growth
1.62M
-72.26%
2.08M-460K-22.12%
Q2 2020
Q2Q % growth
1.18M
-84.22%
1.566M-386K-24.65%
Q1 2020
Q2Q % growth
1.68M
-69.12%
5.79M-4.11M-70.98%
Q4 2019
Q2Q % growth
8.51M 8.757M-247K-2.82%
Q3 2019
Q2Q % growth
5.84M 7.584M-1.744M-23.00%
Q2 2019
Q2Q % growth
7.48M 7.483M-3K-0.04%
Q1 2019
Q2Q % growth
5.44M 7.629M-2.189M-28.69%
SRTS Yearly Revenue VS EstimatesSRTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M 80M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-27.78% -59.37% -60.43% -66.26%
Revenue0% 6.93% 0% 2.35%